Pfizer
Fae Wooding is a seasoned professional in the pharmaceutical and clinical research sectors with extensive experience since July 2012 at Pfizer, currently serving as Senior Director for Global Clinical Supply in Manila Operations. Previous roles at Pfizer include Director and Senior Manager of Clinical Research Pharmacy. Fae Wooding also held the position of Assistant Professor of Pharmacy Practice at MCPHS from July 2006 to June 2012 and completed a Specialty Pharmacy Residency in Primary Care at Providence VA Medical Center from July 2005 to June 2006. Educational qualifications include a Doctor of Pharmacy (Pharm.D.) from the Massachusetts College of Pharmacy and Health Sciences and a Bachelor of Science (B.S.) in Human Physiology from Boston University.
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.